1328 related articles for article (PubMed ID: 26250687)
1. NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
Goedert M
Science; 2015 Aug; 349(6248):1255555. PubMed ID: 26250687
[TBL] [Abstract][Full Text] [Related]
2. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
Duka V; Lee JH; Credle J; Wills J; Oaks A; Smolinsky C; Shah K; Mash DC; Masliah E; Sidhu A
PLoS One; 2013; 8(9):e75025. PubMed ID: 24073234
[TBL] [Abstract][Full Text] [Related]
3. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Carlson GA; Prusiner SB
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
[TBL] [Abstract][Full Text] [Related]
5. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.
Sieczkowski E; Milenkovic I; Venkataramani V; Giera R; Ströbel T; Höftberger R; Liberski PP; Auff E; Wirths O; Bayer TA; Kovacs GG
J Alzheimers Dis; 2015; 44(1):103-14. PubMed ID: 25182745
[TBL] [Abstract][Full Text] [Related]
6. Application of yeast to studying amyloid and prion diseases.
Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
[TBL] [Abstract][Full Text] [Related]
7. Faster disease progression in Parkinson's disease with type 2 diabetes is not associated with increased α-synuclein, tau, amyloid-β or vascular pathology.
de Pablo-Fernández E; Courtney R; Rockliffe A; Gentleman S; Holton JL; Warner TT
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1080-1091. PubMed ID: 33969516
[TBL] [Abstract][Full Text] [Related]
8. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.
Ho CY; Troncoso JC; Knox D; Stark W; Eberhart CG
Brain Pathol; 2014 Jan; 24(1):25-32. PubMed ID: 23714377
[TBL] [Abstract][Full Text] [Related]
9. α-Synuclein modulates tau spreading in mouse brains.
Bassil F; Meymand ES; Brown HJ; Xu H; Cox TO; Pattabhiraman S; Maghames CM; Wu Q; Zhang B; Trojanowski JQ; Lee VM
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33091110
[TBL] [Abstract][Full Text] [Related]
10. Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.
Lloyd GM; Dhillon JS; Gorion KM; Riffe C; Fromholt SE; Xia Y; Giasson BI; Borchelt DR
Mol Neurodegener; 2021 Sep; 16(1):63. PubMed ID: 34503546
[TBL] [Abstract][Full Text] [Related]
11. The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease.
Duyckaerts C; Clavaguera F; Potier MC
Curr Opin Neurol; 2019 Apr; 32(2):266-271. PubMed ID: 30724769
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
13. [The role of proteins in neurodegenerative disease].
Szwed A; Miłowska K
Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
[TBL] [Abstract][Full Text] [Related]
14. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
15. [Conformationally altered proteins cause neurodegenerative diseases].
Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
[TBL] [Abstract][Full Text] [Related]
16. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.
Oláh J; Vincze O; Virók D; Simon D; Bozsó Z; Tõkési N; Horváth I; Hlavanda E; Kovács J; Magyar A; Szũcs M; Orosz F; Penke B; Ovádi J
J Biol Chem; 2011 Sep; 286(39):34088-100. PubMed ID: 21832049
[TBL] [Abstract][Full Text] [Related]
17. Expanding spectrum of prion diseases.
Ayers JI; Paras NA; Prusiner SB
Emerg Top Life Sci; 2020 Sep; 4(2):155-167. PubMed ID: 32803268
[TBL] [Abstract][Full Text] [Related]
18. Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.
Braak H; Del Tredici K
Cold Spring Harb Perspect Biol; 2016 Nov; 8(11):. PubMed ID: 27580631
[TBL] [Abstract][Full Text] [Related]
19. Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.
Li X; James S; Lei P
J Mol Neurosci; 2016 Nov; 60(3):298-304. PubMed ID: 27629562
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's Disease: A Prionopathy?
Vascellari S; Manzin A
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]